N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C93H103F13N18O7 — CID 165049848

IUPACN-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.CN(C)c1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(F)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C25H29F3N4O2.C24H28F3N5O.C22H22F4N4O2.C22H24F3N5O2/c1-23(2)10-8-16(9-11-23)32-14-15-12-20(17(24(3,4)34)13-19(15)31-32)30-22(33)18-6-5-7-21(29-18)25(26,27)28;1-23(2)10-8-16(9-11-23)32-14-15-12-19(20(31(3)4)13-18(15)30-32)29-22(33)17-6-5-7-21(28-17)24(25,26)27;1-21(23)8-6-14(7-9-21)30-12-13-10-17(18(32-2)11-16(13)29-30)28-20(31)15-4-3-5-19(27-15)22(24,25)26;1-29(2)19-11-17-13(12-30(28-17)14-6-8-15(31)9-7-14)10-18(19)27-21(32)16-4-3-5-20(26-16)22(23,24)25/h5-7,12-14,16,34H,8-11H2,1-4H3,(H,30,33);5-7,12-14,16H,8-11H2,1-4H3,(H,29,33);3-5,10-12,14H,6-9H2,1-2H3,(H,28,31);3-5,10-12,14-15,31H,6-9H2,1-2H3,(H,27,32)
InChIKeyPMJZGMDQTKFVOH-UHFFFAOYSA-N
MW1831.94 g/mol
LogP21.78
Rot. Bonds16

About N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 165049848) has the molecular formula C93H103F13N18O7 and a molecular weight of 1831.94 g/mol. Its IUPAC name is N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID165049848
Molecular FormulaC93H103F13N18O7
Molecular Weight1831.94 g/mol
Exact Mass1830.80
IUPAC NameN-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.CN(C)c1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(F)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C25H29F3N4O2.C24H28F3N5O.C22H22F4N4O2.C22H24F3N5O2/c1-23(2)10-8-16(9-11-23)32-14-15-12-20(17(24(3,4)34)13-19(15)31-32)30-22(33)18-6-5-7-21(29-18)25(26,27)28;1-23(2)10-8-16(9-11-23)32-14-15-12-19(20(31(3)4)13-18(15)30-32)29-22(33)17-6-5-7-21(28-17)24(25,26)27;1-21(23)8-6-14(7-9-21)30-12-13-10-17(18(32-2)11-16(13)29-30)28-20(31)15-4-3-5-19(27-15)22(24,25)26;1-29(2)19-11-17-13(12-30(28-17)14-6-8-15(31)9-7-14)10-18(19)27-21(32)16-4-3-5-20(26-16)22(23,24)25/h5-7,12-14,16,34H,8-11H2,1-4H3,(H,30,33);5-7,12-14,16H,8-11H2,1-4H3,(H,29,33);3-5,10-12,14H,6-9H2,1-2H3,(H,28,31);3-5,10-12,14-15,31H,6-9H2,1-2H3,(H,27,32)
InChIKeyPMJZGMDQTKFVOH-UHFFFAOYSA-N
XLogP21.78
TPSA295.41 Ų
H-Bond Donors6
H-Bond Acceptors21
Rotatable Bonds16
Heavy Atoms131
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001831.94
LogP ≤ 521.78
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1021

Analyze N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 165049848) is N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is CC1(C)CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.CN(C)c1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(F)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is PMJZGMDQTKFVOH-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29F3N4O2.C24H28F3N5O.C22H22F4N4O2.C22H24F3N5O2/c1-23(2)10-8-16(9-11-23)32-14-15-12-20(17(24(3,4)34)13-19(15)31-32)30-22(33)18-6-5-7-21(29-18)25(26,27)28;1-23(2)10-8-16(9-11-23)32-14-15-12-19(20(31(3)4)13-18(15)30-32)29-22(33)17-6-5-7-21(28-17)24(25,26)27;1-21(23)8-6-14(7-9-21)30-12-13-10-17(18(32-2)11-16(13)29-30)28-20(31)15-4-3-5-19(27-15)22(24,25)26;1-29(2)19-11-17-13(12-30(28-17)14-6-8-15(31)9-7-14)10-18(19)27-21(32)16-4-3-5-20(26-16)22(23,24)25/h5-7,12-14,16,34H,8-11H2,1-4H3,(H,30,33);5-7,12-14,16H,8-11H2,1-4H3,(H,29,33);3-5,10-12,14H,6-9H2,1-2H3,(H,28,31);3-5,10-12,14-15,31H,6-9H2,1-2H3,(H,27,32).
What are the key properties of N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 1831.94 g/mol, XLogP of 21.78, 16 rotatable bonds, 6 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-fluoro-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 165049848), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).